These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. IMP-GMP specific cytosolic 5'-nucleotidase regulates nucleotide pool and prodrug metabolism. Cividini F; Filoni DN; Pesi R; Allegrini S; Camici M; Tozzi MG Biochim Biophys Acta; 2015 Jul; 1850(7):1354-61. PubMed ID: 25857773 [TBL] [Abstract][Full Text] [Related]
7. Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine. Galmarini CM; Thomas X; Graham K; El Jafaari A; Cros E; Jordheim L; Mackey JR; Dumontet C Br J Haematol; 2003 Jul; 122(1):53-60. PubMed ID: 12823345 [TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of pigeon breast muscle cytosolic 5'-nucleotidase-I (cN-I). Tkacz-Stachowska K; Lechward K; Skladanowski AC Acta Biochim Pol; 2005; 52(4):789-96. PubMed ID: 15940349 [TBL] [Abstract][Full Text] [Related]
9. Enforced expression of cytosolic 5'-nucleotidase I confers resistance to nucleoside analogues in vitro but systemic chemotherapy toxicity precludes in vivo selection. Gray T; Morrey EL; Gangadharan B; Sumter TF; Spychala J; Archer DR; Spencer HT Cancer Chemother Pharmacol; 2006 Jul; 58(1):117-28. PubMed ID: 16362297 [TBL] [Abstract][Full Text] [Related]
10. Drug resistance in hematologic malignancies. Dalton W Clin Adv Hematol Oncol; 2005 Apr; 3(4):267-8. PubMed ID: 16166998 [No Abstract] [Full Text] [Related]
11. Lack of cross-resistance with gemcitabine and cytarabine in cladribine-resistant HL60 cells with elevated 5'-nucleotidase activity. Schirmer M; Stegmann AP; Geisen F; Konwalinka G Exp Hematol; 1998 Dec; 26(13):1223-8. PubMed ID: 9845378 [TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of inhibitors of cytoplasmic 5'-nucleotidase cN-II issued from virtual screening. Jordheim LP; Marton Z; Rhimi M; Cros-Perrial E; Lionne C; Peyrottes S; Dumontet C; Aghajari N; Chaloin L Biochem Pharmacol; 2013 Feb; 85(4):497-506. PubMed ID: 23220537 [TBL] [Abstract][Full Text] [Related]
13. Initial studies to define the physiologic role of cN-II. Filoni DN; Pesi R; Careddu MG; Camici M; Allegrini S; Collavoli A; Scarfone I; Zucchi F; Galli A; Tozzi MG Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1155-60. PubMed ID: 22132970 [TBL] [Abstract][Full Text] [Related]
14. Cell proliferation and drug sensitivity of human glioblastoma cells are altered by the stable modulation of cytosolic 5'-nucleotidase II. Cividini F; Cros-Perrial E; Pesi R; Machon C; Allegrini S; Camici M; Dumontet C; Jordheim LP; Tozzi MG Int J Biochem Cell Biol; 2015 Aug; 65():222-9. PubMed ID: 26079827 [TBL] [Abstract][Full Text] [Related]
15. Determination of the enzymatic activity of cytosolic 5'-nucleotidase cN-II in cancer cells: development of a simple analytical method and related cell line models. Jordheim LP; Puy JY; Cros-Perrial E; Peyrottes S; Lefebvre I; Périgaud C; Dumontet C Anal Bioanal Chem; 2015 Jul; 407(19):5747-58. PubMed ID: 25998135 [TBL] [Abstract][Full Text] [Related]
16. On the physiological role of cytosolic 5'-nucleotidase II (cN-II): pathological and therapeutical implications. Tozzi MG; Pesi R; Allegrini S Curr Med Chem; 2013; 20(34):4285-91. PubMed ID: 23992310 [TBL] [Abstract][Full Text] [Related]
18. Structure and Mechanisms of NT5C2 Mutations Driving Thiopurine Resistance in Relapsed Lymphoblastic Leukemia. Dieck CL; Tzoneva G; Forouhar F; Carpenter Z; Ambesi-Impiombato A; Sánchez-Martín M; Kirschner-Schwabe R; Lew S; Seetharaman J; Tong L; Ferrando AA Cancer Cell; 2018 Jul; 34(1):136-147.e6. PubMed ID: 29990496 [TBL] [Abstract][Full Text] [Related]
19. Screening for gene mutations: will identification of NT5C2 mutations help predict the chance of relapse in acute lymphoblastic leukemia? Meyer JA; Carroll WL; Bhatla T Expert Rev Hematol; 2013 Jun; 6(3):223-4. PubMed ID: 23782074 [No Abstract] [Full Text] [Related]
20. Mechanistic studies on bovine cytosolic 5'-nucleotidase II, an enzyme belonging to the HAD superfamily. Allegrini S; Scaloni A; Careddu MG; Cuccu G; D'Ambrosio C; Pesi R; Camici M; Ferrara L; Tozzi MG Eur J Biochem; 2004 Dec; 271(23-24):4881-91. PubMed ID: 15606776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]